Gyan Varma And Sushmi Dey

Stories by Gyan Varma And Sushmi Dey

How drug firms dodge government rules

How drug firms dodge government rules

Rediff.com   5 Aug 2013

A probe finds several pharma majors in breach of the law; and in turn they blame the government.

How sand mafia framed IAS officer Durga

How sand mafia framed IAS officer Durga

Rediff.com   2 Aug 2013

Uttar Pradesh is under the scanner again as that state IAS Association has taken on CM Akhilesh Yadav for the suspension of Durga Shakti Nagpal, who campaigned against the sand mafia

New drug pricing order challenged in court

New drug pricing order challenged in court

Rediff.com   1 Aug 2013

The move is expected to delay the introduction of low-priced medicines in the market.

Hi-tech Modi to get million-strong IT team to boost 2014 campaign

Hi-tech Modi to get million-strong IT team to boost 2014 campaign

Rediff.com   29 Jul 2013

To strengthen Narendra Modi's efforts to bring victory for the Bharatiya Janata Party in the 2014 Lok Sabha elections, the party has decided to build a team of over one million people to spread the party's message to voters. These supporters, not necessarily party members, will use various methods, including SMS and social media, to reach out to voters.

US regulator tightens drug approval norms

US regulator tightens drug approval norms

Rediff.com   29 Jul 2013

Companies asked to give data for three batches instead of one; move may lead to significant rise in development cost of generics

Jet-Etihad deal hits Sebi, DIPP roadblocks

Jet-Etihad deal hits Sebi, DIPP roadblocks

Rediff.com   26 Jul 2013

Concerns over effective control not addressed in the second revised shareholders' agreement, says DIPP; Sebi opposes commercial cooperation pact

9 drug firms may have to gulp Rs 2.5k-cr pill

9 drug firms may have to gulp Rs 2.5k-cr pill

Rediff.com   19 Jul 2013

Face NPPA fine for overcharging on anti-asthma drug

Govt to review suspension of 3 drugs

Govt to review suspension of 3 drugs

Rediff.com   10 Jul 2013

Besides opposing the suspension of three medicines, the sector has also questioned the process adopted by the government.

Twenty-five essential drugs to see 90% decline in prices

Twenty-five essential drugs to see 90% decline in prices

Rediff.com   6 Jul 2013

The latest price revision includes mostly cardiovascular drugs, anti-bacterials, anti-herpes, contraceptives and gastrointestinal medicines

Finally, health ministry acts on Uttarakhand

Finally, health ministry acts on Uttarakhand

Rediff.com   26 Jun 2013

Fearing outbreak of epidemics, the ministry is sending a high level team to review the public health measures in the area

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com   24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com   23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

Prices of key drugs to be cut by up to half

Prices of key drugs to be cut by up to half

Rediff.com   17 Jun 2013

The National Pharmaceutical Pricing Authority will soon notify prices of as many as 150 packs of essential medicines in line with the new pharma pricing policy, according to official sources.

Sun Pharma sues Novartis in US court

Sun Pharma sues Novartis in US court

Rediff.com   13 Jun 2013

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New Jersey, demanding rights to launch a generic version of the cancer drug before the Novartis patent expires.

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com   12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

Airlines under CCI scanner for cargo fuel surcharge

Airlines under CCI scanner for cargo fuel surcharge

Rediff.com   12 Jun 2013

The complaint was lodged by Mumbai-based Express Industry Council of India, which represented major express courier and cargo companies such as DTDC, Aramex India, Blue Dart, DHL Express, GATI and First Flight.

Ranbaxy drugs cleared FDA test before import alert

Ranbaxy drugs cleared FDA test before import alert

Rediff.com   11 Jun 2013

FDA had also issued warning letters to Ranbaxy's Paonta Sahib and Dewas facilities as it found extensive problems and deviations from manufacturing norms.

Drug shortage likely as chemists run on limited stock

Drug shortage likely as chemists run on limited stock

Rediff.com   8 Jun 2013

There may be shortage of drugs till pharmaceutical companies supply new batches with revised MRPs.

Apollo Pharmacy halts sale of Ranbaxy drugs

Apollo Pharmacy halts sale of Ranbaxy drugs

Rediff.com   7 Jun 2013

Apollo Pharmacy, the country's largest branded drug retail network with over 1,500 outlets, has temporarily suspended sale of medicines manufactured by Ranbaxy Laboratories. It has also stopped further procurement from the company for now.

Singapore could be possible site for Ranbaxy arbitration

Singapore could be possible site for Ranbaxy arbitration

Rediff.com   3 Jun 2013

The 2008 deal agreement contains provisions of arbitration to be held in that country.